Back
Xeris Biopharma Holdings Stock Price Chart
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Buy
77
XERS
Xeris Biopharma Holdings
Last Price:
3.11
Seasonality Move:
-0.27%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade- The current trend is moderately bearish and XERS is experiencing selling pressure, which indicates risk of future bearish movement.
Xeris Biopharma Holdings Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.28 | Sell |
| 20-day SMA: | 3.2 | Sell |
| 50-day SMA: | 2.99 | Buy |
| 200-day SMA: | 2.49 | Buy |
| 8-day EMA: | 3.24 | Sell |
| 20-day EMA: | 3.19 | Sell |
| 50-day EMA: | 3.01 | Buy |
| 200-day EMA: | 2.57 | Buy |
Xeris Biopharma Holdings Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 50.18 | Buy |
| Chaikin Money Flow: | -1864095 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3 - 3.3) | Sell |
| Bollinger Bands (100): | (2.37 - 3.07) | Buy |
Xeris Biopharma Holdings Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Xeris Biopharma Holdings Stock
Is Xeris Biopharma Holdings Stock a Buy?
- Xeris Biopharma Holdings share price is 3.15 while XERS 8-day simple moving average is 3.28, which is a Sell signal.
- The stock price of XERS is 3.15 while Xeris Biopharma Holdings 20-day SMA is 3.20, which makes it a Sell.
- Xeris Biopharma Holdings 50-day simple moving average is 2.99 while XERS share price is 3.15, making it a Buy technically.
- XERS stock price is 3.15 and Xeris Biopharma Holdings 200-day simple moving average is 2.49, creating a Buy signal.
XERS Technical Analysis vs Fundamental Analysis
Buy
77
Xeris Biopharma Holdings (XERS)
is a Buy
Is Xeris Biopharma Holdings a Buy or a Sell?
-
Xeris Biopharma Holdings stock is rated a Buy
The current Xeris Biopharma Holdings [XERS] share price is $3.15. The Score for XERS is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
Xeris Biopharma Holdings Stock Info
Market Cap:
469.35M
Price in USD:
3.15
Share Volume:
1.86M
Xeris Biopharma Holdings 52-Week Range
52-Week High:
3.64
52-Week Low:
1.46
Buy
77
Xeris Biopharma Holdings (XERS)
is a Buy
Xeris Biopharma Holdings Share Price Forecast
-
What is the Xeris Biopharma Holdings stock price today?
The Xeris Biopharma Holdings stock price is 3.15 USD today. -
Will XERS stock go up or go down?
Xeris Biopharma Holdings> share price is forecast to RISE/FALL based on technical indicators -
Is Xeris Biopharma Holdings overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Xeris Biopharma Holdings is not overvalued.
Is Xeris Biopharma Holdings Stock a Buy?
- Xeris Biopharma Holdings share price is 3.15 while XERS 8-day exponential moving average is 3.24, which is a Sell signal.
- The stock price of XERS is 3.15 while Xeris Biopharma Holdings 20-day EMA is 3.19, which makes it a Sell.
- Xeris Biopharma Holdings 50-day exponential moving average is 3.01 while XERS share price is 3.15, making it a Buy technically.
- XERS stock price is 3.15 and Xeris Biopharma Holdings 200-day simple moving average is 2.57, creating a Buy signal.
Fundamental Analysis of Xeris Biopharma Holdings
Is Xeris Biopharma Holdings a good investment?
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.06 per share.
Technical Analysis of Xeris Biopharma Holdings
Should I short Xeris Biopharma Holdings stock?
- XERS Moving Average Covergence Divergence (MACD) indicator is 0.08, suggesting Xeris Biopharma Holdings is a Buy
- Xeris Biopharma Holdings Relative Strength Index (RSI) is 50.18, which suggest Xeris Biopharma Holdings is overbought
- The Bollinger Bands (25) for Xeris Biopharma Holdings is (3 - 3.3), which suggest Xeris Biopharma Holdings is a Buy
- The Bollinger Bands (100) for Xeris Biopharma Holdings is (2.37 - 3.07), which suggest Xeris Biopharma Holdings is a Buy
* Xeris Biopharma Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.